March 12, 2020 / 4:20 PM / 23 days ago

BRIEF-Kitov Pharma Provides Update On Planned U.S. Launch Of Consensi And Provides Three-Year Revenue Forecast

March 12 (Reuters) - Kitov Pharma Ltd:

* KITOV PHARMA PROVIDES UPDATE ON PLANNED U.S. LAUNCH OF CONSENSI™ AND PROVIDES THREE-YEAR REVENUE FORECAST

* KITOV PHARMA LTD - EXPECTS TO RECEIVE BETWEEN $28 MILLION AND $36 MILLION IN MILESTONE AND ROYALTY REVENUES FROM 2020 THROUGH 2022

* KITOV PHARMA LTD - EXPECTED TO BEGIN SELLING CONSENSI IN U.S. IN MAY 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below